Dana-Farber Cancer Institute will pay $15m to resolve allegations that it violated the False Claims Act by making false statements related to National Institutes of Health (NIH) research grants.
The Boston-based cancer treatment and research center “caused the submission of false claims to NIH by falsely certifying compliance with grant
Register for free to keep reading
To continue reading this article and unlock full access to GRIP, register now. You’ll enjoy free access to all content until our subscription service launches in early 2026.
- Unlimited access to industry insights
- Stay on top of key rules and regulatory changes with our Rules Navigator
- Ad-free experience with no distractions
- Regular podcasts from trusted external experts
- Fresh compliance and regulatory content every day
